QCM
ADMA icon

Quantinno Capital Management’s ADMA Biologics ADMA Stock Holding History

Quantinno Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
330,681
+288,140
+677% +$2.63M ﹤0.01% 1694
2026
Q1 		$383K Buy
42,541
+10,108
+31% +$160K ﹤0.01% 2894
2025
Q4 		$592K Buy
32,433
+21,871
+207% +$369K ﹤0.01% 2255
2025
Q3 		$155K Buy
+10,562
New +$181K ﹤0.01% 2824

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quantinno Capital Management's ADMA Position: Q2 2026 in Review

Quantinno Capital Management increased its ADMA Biologics (ADMA) stake by 677% in Q2 2026, buying an estimated $2.63M and bringing the position to 330,681 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Quantinno Capital Management first reported a position in ADMA in Q3 2025 and has held it in 4 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Quantinno Capital Management held 330,681 shares of ADMA Biologics worth $2.77M as of Q2 2026.
  • Quantinno Capital Management bought 288,140 ADMA Biologics shares in Q2 2026, an estimated $2.63M.
  • ADMA Biologics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1694 holding.
  • Quantinno Capital Management first reported a position in ADMA Biologics in Q3 2025 and has held it in 4 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.